title: ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation.
authors.forename: Karin
authors.initials: K
authors.lastname: Lövgren Bengtsson
authors.forename: Bror
authors.initials: B
authors.lastname: Morein
authors.forename: Albert Dme
authors.initials: AD
authors.lastname: Osterhaus
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002626:Chemistry, Pharmaceutical / Q000379:methods; D004339:Drug Compounding; D006801:Humans; D016882:ISCOMs / Q000008:administration & dosage / Q000494:pharmacology*; D014612:Vaccines / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D016882:ISCOMs; D014612:Vaccines